What is Athelas?
Athelas is dedicated to bringing simple, life-changing healthcare products to individuals worldwide. Its core offering, the Athelas Remote Patient Monitoring (RPM) system, empowers healthcare providers to continuously track vital patient metrics such as blood pressure, weight, and blood glucose without requiring in-person clinic visits. This innovative approach significantly enhances patient health outcomes and engagement while simultaneously reducing the incidence of hospitalizations. The company operates within the rapidly evolving health technology landscape, focusing on solutions that bridge the gap between traditional healthcare and accessible, patient-centric monitoring.
How much funding has Athelas raised?
Athelas has raised a total of $135.5M across 2 funding rounds:
Other Financing Round
$3.5M
Unspecified
$132M
Other Financing Round (2017): $3.5M with participation from Fifty Years, Liquid2 Ventures, Steamboat Ventures, and Initialized Capital
Unspecified (2022): $132M led by General Catalyst, Initialized Capital, Human Capital, Y Combinator, GREENOAKS, Tribe Capital Growth Corp I, and Sequoia Capital
Key Investors in Athelas
General Catalyst
General Catalyst is a venture capital firm that identifies and supports transformational business opportunities across multiple sectors and stages, deploying capital strategically to back ambitious entrepreneurs and management teams. They partner with founders to accelerate growth and build enduring enterprises through deep sector expertise and operational experience.
Initialized Capital
Initialized Capital is a venture capital firm focused on supporting seed-stage founders across diverse sectors including enterprise SaaS, sustainability, and health, providing essential tools and guidance for long-term success. They champion innovation and aim to shape the future of technology and business.
Human Capital
Human Capital is a venture firm that invests in and helps build engineering teams for engineering-centric startups, having backed notable companies like Brex and Snowflake. They focus on placing early hires at high-growth unicorns.
What's next for Athelas?
With the recent major strategic investment, Athelas is poised to further enhance its technological capabilities and expand its market reach. The substantial enterprise-level funding suggests a focus on scaling operations, refining its RPM platform, and potentially exploring new product lines or geographical markets. This capital infusion will likely enable Athelas to solidify its position as a leader in remote patient monitoring, driving innovation in preventative care and chronic disease management. The company's strategic direction will likely involve deepening partnerships with healthcare providers and payers to integrate its solutions more seamlessly into existing healthcare ecosystems, ultimately aiming to improve patient care efficiency and accessibility on a global scale.
See full Athelas company page
